SCPH scPharmaceuticals, Inc.: יחס שווי פעילות לרווח לפני ריבית, מסים ופחת

The EV/EBITDA price chart for scPharmaceuticals Inc. (SCPH) on GURU.Markets is . scPharmaceuticals Inc. (SCPH) automates the creation of injections using algorithms, although medical supervision remains with humans. The business is implementing the Furoscix system for home treatment of heart failure, reducing clinic costs. This unique product allows for the effective displacement of hospital therapy, ensuring high margins and protection against cheap generics.

Supply chain disruptions in electronics and component logistics for scPharmaceuticals Inc. therapies make operational efficiency critical. This metric compares the business value, including net debt, against earnings before interest, taxes, depreciation, and amortization. By analyzing the historical EV/EBITDA trajectory, an investor determines the asset's payback period excluding tax effects. This indicator helps identify stock overvaluation relative to the company's actual ability to generate cash flow.